Business ❯ Finance ❯ Investments ❯ Stocks

Biotech Stocks

Immunovant Shares Surge on Strong Rheumatoid Arthritis Data for IMVT-1402

The strong showing in hard-to-treat patients signals momentum for the company’s autoimmune pipeline.

Viking Therapeutics Pushes VK2735 Through Pivotal Trials as Next Enrollment Milestone Nears

Wall Street Sees 175% Upside for Viking Therapeutics on Obesity Drug Bet

Alumis TYK2 Pill Hits Phase 3 Goals in Psoriasis as Stock Jumps and $175 Million Offering Is Planned

Terns’ TERN-701 Shows Strong CML Responses in CARDINAL, Setting 320 mg and 500 mg Phase 2 Doses

FDA Accepts Replimune’s Resubmitted RP1 Melanoma Filing, Sets April 2026 Decision

AbbVie Extends Rinvoq U.S. Exclusivity to 2037 as AI Biotechs Move From Models to Medicines